Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Pasello

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Applied Microbiology and Biotechnology|December 22, 2015
Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcomaDiego Moricoli, Damiano Cosimo Carbonella, Sabrina Dominici, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2019
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activityCinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, et al.
Molecular Cancer Therapeutics|October 20, 2021
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 ActivityTommaso Balestra, Maria Cristina Manara, Maria Antonella Laginestra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adultsDonato Gemmati, Alessia Ongaro, Gian L Scapoli, et al.
Cancer Immunology Research|December 5, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and MacrophagesMaria Cristina Manara, Cristina Manferdini, Camilla Cristalli, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cancer Research|December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 SarcomaMarianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Applied Microbiology and Biotechnology|December 22, 2015
Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcomaDiego Moricoli, Damiano Cosimo Carbonella, Sabrina Dominici, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2019
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activityCinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, et al.
Molecular Cancer Therapeutics|October 20, 2021
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 ActivityTommaso Balestra, Maria Cristina Manara, Maria Antonella Laginestra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adultsDonato Gemmati, Alessia Ongaro, Gian L Scapoli, et al.
Cancer Immunology Research|December 5, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and MacrophagesMaria Cristina Manara, Cristina Manferdini, Camilla Cristalli, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cancer Research|December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 SarcomaMarianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Pageof 5